Decentralized trials are transforming the clinical research environment at a rapid pace. This patient-centric approach to research makes it possible to accelerate recruitment by allowing more diverse patient populations to participate in clinical research while lowering the burden of participant trial participation.
In this session, we will explore the site perspective on what DCT implementation deliveries look like and how these models can help foster successful partnerships among sites, sponsors and patients. Our panel of experts will share key learnings "from the field" and what technologies and processes sites are using to be a more effective partner in decentralized trials design.
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
